A patient-derived, pan-cancer EMT signature identifies global molecular alterations and immune target enrichment following epithelial-to-mesenchymal transition MP Mak, P Tong, L Diao, RJ Cardnell, DL Gibbons, WN William, ... Clinical Cancer Research 22 (3), 609-620, 2016 | 432 | 2016 |
Nivolumab plus ipilimumab versus EXTREME regimen as first-line treatment for recurrent/metastatic squamous cell carcinoma of the head and neck: the final results of CheckMate 651 RI Haddad, K Harrington, M Tahara, RL Ferris, M Gillison, J Fayette, ... Journal of Clinical Oncology 41 (12), 2166, 2023 | 55 | 2023 |
Percutaneous transhepatic biliary drainage in patients with advanced solid malignancies: prognostic factors and clinical outcomes MC Teixeira, MP Mak, DF Marques, F Capareli, FC Carnevale, ... Journal of gastrointestinal cancer 44 (4), 398-403, 2013 | 54 | 2013 |
Cisplatin based chemoradiation late toxicities in head and neck squamous cell carcinoma patients. CGJ Rivelli TG, Mak MP, Martins RE, da Costa E Silva VT Discovery Medicine 20 (108), 57-66, 2015 | 47 | 2015 |
Pulmonary nodules in patients with nonpulmonary cancer: not always metastases R Caparica, MP Mak, CH Rocha, PHI Velho, P Viana, MRL Moura, ... Journal of Global Oncology 2 (3), 138-144, 2016 | 46 | 2016 |
Malignancy-Related Hypercalcemia in Advanced Solid Tumors: Survival Outcomes REO Ramos, M Perez Mak, MFS Alves, GHM Piotto, TK Takahashi, ... Journal of global oncology 3 (6), 728-733, 2017 | 44 | 2017 |
Advanced prostate cancer as a cause of oncogenic osteomalacia: an underdiagnosed condition MP Mak, VTC e Silva, RM Martin, AM Lerario, L Yu, PMG Hoff, ... Supportive Care in Cancer 20 (9), 2195-2197, 2012 | 40 | 2012 |
First-Line Selpercatinib or Chemotherapy and Pembrolizumab in RET Fusion–Positive NSCLC C Zhou, B Solomon, HH Loong, K Park, M Pérol, E Arriola, S Novello, ... New England Journal of Medicine, 2023 | 39 | 2023 |
Erdafitinib in patients with advanced solid tumours with FGFR alterations (RAGNAR): an international, single-arm, phase 2 study S Pant, M Schuler, G Iyer, O Witt, T Doi, S Qin, J Tabernero, DA Reardon, ... The Lancet Oncology 24 (8), 925-935, 2023 | 35 | 2023 |
First-line atezolizumab monotherapy versus single-agent chemotherapy in patients with non-small-cell lung cancer ineligible for treatment with a platinum-containing regimen … SM Lee, C Schulz, K Prabhash, D Kowalski, A Szczesna, B Han, ... The Lancet, 2023 | 33 | 2023 |
Postradiation matrix metalloproteinase-20 expression and its impact on dental micromorphology and radiation-related caries W Gomes-Silva, AC Prado-Ribeiro, TB Brandao, K Morais-Faria, ... Caries research 51 (3), 216-224, 2017 | 33 | 2017 |
Evolução do zumbido e da audição em pacientes com audiometria tonal normal TG Sanchez, MP Mak, MEB Pedalini, CPD Levy, RF Bento Arq Int Otorrinolaringol 9 (3), 220-27, 2005 | 32 | 2005 |
Palliative chemotherapy outcomes in patients with ECOG-PS higher than 1 R Caires-Lima, K Cayres, B Protásio, I Caires, J Andrade, L Rocha, ... Ecancermedicalscience 12, 831, 2018 | 31 | 2018 |
Targeting the epidermal growth factor receptor for head and neck cancer chemoprevention MP Mak, WN William Jr Oral oncology 50 (10), 918-923, 2014 | 31 | 2014 |
LBA36 Nivolumab (N)+ ipilimumab (I) vs EXTREME as first-line (1L) treatment (tx) for recurrent/metastatic squamous cell carcinoma of the head and neck (R/M SCCHN): Final … A Argiris, K Harrington, M Tahara, RL Ferris, M Gillison, J Fayette, A Daste, ... Annals of Oncology 32, S1310-S1311, 2021 | 26 | 2021 |
Is there still a role for induction chemotherapy in locally advanced head and neck cancer? MP Mak, BS Glisson Current opinion in oncology 26 (3), 247-251, 2014 | 20 | 2014 |
Modified FLOX as first-line chemotherapy for metastatic colorectal cancer patients in the public health system in Brazil: Effectiveness and cost-utility analysis DR Nebuloni, MP Mak, FH Souza, DF Saragiotto, T Júlio, G De Castro Jr, ... Molecular and clinical oncology 1 (1), 175-179, 2013 | 20 | 2013 |
A multicenter, multinational analysis of mitomycin C in refractory metastatic colorectal cancer R Ferrarotto, K Machado, MP Mak, N Shah, TK Takahashi, FP Costa, ... European Journal of Cancer 48 (6), 820-826, 2012 | 20 | 2012 |
Cardiac Safety of (Neo) Adjuvant Trastuzumab in the Community Setting: A Single-Center Experience LG da Fonseca, D de Melo Gagliato, TK Takahashi, MP Mak, ... Breast Care 9 (4), 255, 2014 | 14 | 2014 |
Orbital apex syndrome affecting head and neck cancer patients: A case series AC Prado-Ribeiro, AC Luiz, MA Montezuma, MP Mak, AR Santos-Silva, ... Medicina oral, patologia oral y cirugia bucal 22 (3), e354, 2017 | 12 | 2017 |